UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (239) 239
life sciences & biomedicine (228) 228
breast cancer (214) 214
oncology (213) 213
humans (198) 198
female (184) 184
middle aged (145) 145
adult (114) 114
aged (114) 114
breast neoplasms - pathology (95) 95
breast neoplasms - drug therapy (92) 92
medicine & public health (83) 83
cancer (68) 68
metastasis (62) 62
surgical oncology (56) 56
surgery (53) 53
care and treatment (51) 51
breast neoplasms - genetics (50) 50
chemotherapy (48) 48
treatment outcome (48) 48
obstetrics & gynecology (47) 47
research (46) 46
antineoplastic combined chemotherapy protocols - therapeutic use (43) 43
cancer research (43) 43
chemistry (38) 38
breast neoplasms - mortality (37) 37
risk factors (37) 37
metallurgy (36) 36
prognosis (35) 35
compounds thereof (34) 34
inorganic chemistry (34) 34
non-metallic elements (34) 34
disease-free survival (33) 33
neoplasm staging (33) 33
analysis (32) 32
clinical trials (32) 32
aged, 80 and over (31) 31
breast neoplasms - metabolism (31) 31
epidermal growth factor (31) 31
japan (31) 31
patients (31) 31
case-control studies (30) 30
oncology, experimental (29) 29
metastases (28) 28
adjuvant treatment (27) 27
breast neoplasms - surgery (27) 27
health aspects (27) 27
trastuzumab (27) 27
cancer therapies (26) 26
tumors (26) 26
cancer patients (25) 25
erbb-2 protein (25) 25
receptor, erbb-2 - metabolism (23) 23
neoplasm metastasis (22) 22
womens health (22) 22
antimitotic agents (21) 21
antineoplastic agents (21) 21
diagnostic radiology (21) 21
genetic aspects (21) 21
genetic predisposition to disease (21) 21
postmenopausal women (21) 21
antineoplastic combined chemotherapy protocols - adverse effects (20) 20
neoadjuvant therapy (20) 20
original (20) 20
breast neoplasms - epidemiology (19) 19
genotype (19) 19
imaging / radiology (19) 19
interventional radiology (19) 19
medical research (19) 19
original article (19) 19
chemotherapy, adjuvant (18) 18
receptor, erbb-2 - analysis (18) 18
survival (18) 18
breast neoplasms - chemistry (17) 17
genetics (17) 17
metastatic breast cancer (17) 17
receptors, estrogen - metabolism (17) 17
drug administration schedule (16) 16
drug therapy (16) 16
estrogen (16) 16
postmenopause (16) 16
receptors, estrogen - analysis (16) 16
survival analysis (16) 16
cyclophosphamide - administration & dosage (15) 15
endocrine therapy (15) 15
genetics & heredity (15) 15
studies (15) 15
follow-up studies (14) 14
kaplan-meier estimate (14) 14
medical prognosis (14) 14
neutropenia (14) 14
polymorphism, single nucleotide (14) 14
antineoplastic agents - therapeutic use (13) 13
asian continental ancestry group - genetics (13) 13
genome-wide association study (13) 13
immunohistochemistry (13) 13
lymphatic metastasis (13) 13
menopause (13) 13
odds ratio (13) 13
polymorphism, genetic (13) 13
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 07/2015, Volume 373, Issue 3, pp. 209 - 219
Journal Article
Annals of oncology, ISSN 0923-7534, 11/2015, Volume 26, p. vii11
Journal Article
The New England journal of medicine, ISSN 1533-4406, 06/2017, Volume 376, Issue 22, pp. 2147 - 2159
Journal Article
The lancet oncology, ISSN 1470-2045, 04/2016, Volume 17, Issue 4, pp. 425 - 439
Journal Article
Cancer science, ISSN 1347-9032, 03/2018, Volume 109, Issue 3, pp. 803 - 813
This single‐arm, open‐label, phase II study in 42 Japanese postmenopausal patients with estrogen receptor‐positive/human epidermal growth factor receptor... 
letrozole | cyclin‐dependent kinase | advanced breast cancer | Japanese | palbociclib | cyclin-dependent kinase | Life Sciences & Biomedicine | Oncology | Science & Technology | Piperazines - administration & dosage | Triazoles - administration & dosage | Triazoles - adverse effects | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Pyridines - pharmacokinetics | Nitriles - pharmacokinetics | Nitriles - administration & dosage | Pyridines - adverse effects | Aged, 80 and over | Postmenopause | Adult | Female | Triazoles - pharmacokinetics | Piperazines - pharmacokinetics | Pyridines - administration & dosage | Drug Administration Schedule | Treatment Outcome | Breast Neoplasms - drug therapy | Piperazines - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Aged | Nitriles - adverse effects | Letrozole | Antimitotic agents | Care and treatment | Oncology, Experimental | Estrogen | Breast cancer | Postmenopausal women | Research | Drug therapy, Combination | Drug therapy | Antineoplastic agents | Cancer | Plasma | Medical research | Research funding | Menopause | Estrogen receptors | Endocrine therapy | Metastasis | Survival | ErbB-2 protein | Disease control | Patients | Post-menopause | Studies | Stomatitis | Epidermal growth factor | Womens health | Cell cycle | Pharmacokinetics | Drug dosages | Neutropenia | Tumors | Index Medicus | Original
Journal Article
The New England journal of medicine, ISSN 1533-4406, 11/2018, Volume 379, Issue 22, pp. 2108 - 2121
Journal Article
The lancet oncology, ISSN 1470-2045, 07/2017, Volume 18, Issue 7, pp. 904 - 916
Summary Background Phosphatidylinositol 3-kinase (PI3K) pathway activation is a hallmark of endocrine therapy-resistant, hormone receptor-positive breast... 
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Estradiol - analogs & derivatives | Humans | Middle Aged | Aminopyridines - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Response Evaluation Criteria in Solid Tumors | Alanine Transaminase - blood | Receptors, Estrogen - analysis | Fulvestrant | Receptors, Progesterone - analysis | Breast Neoplasms - chemistry | Neoplasm Metastasis | Hyperglycemia - chemically induced | DNA, Neoplasm - blood | DNA Mutational Analysis | Exanthema - chemically induced | Postmenopause | Female | Morpholines - adverse effects | Aminopyridines - administration & dosage | Drug Eruptions - etiology | Double-Blind Method | Morpholines - administration & dosage | Estradiol - administration & dosage | Survival Rate | Signal Transduction - genetics | Breast Neoplasms - drug therapy | Phosphatidylinositol 3-Kinases - genetics | Disease-Free Survival | Retreatment | Breast Neoplasms - genetics | Class I Phosphatidylinositol 3-Kinases | Aspartate Aminotransferases - blood | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Aged | Biomarkers, Tumor - genetics | Receptor, ErbB-2 - analysis | Antimitotic agents | Medical colleges | Clinical trials | Product development | Breast cancer | Postmenopausal women | Hormones | Antineoplastic agents | Analysis | Index Medicus
Journal Article